PPARG and Mental deterioration: In addition, prevention of cognitive decline in an intracerebroventricular infusion model of Aβ1-40 by telmisartan, a partial PPARγ agonist, was abolished when mice were treated with the PPARγ antagonist GW9662, further supporting a role of PPARγ for neuroprotection [82].